Cronos Group(NASDAQ) CRON

Cronos Group Inc. makes cannabis for medical and adult use. They help people find wellness through hemp and cannabinoid items. The company sells these products in several global markets.

Cannabinoids for Every Occasion

• Cannabis Flower: Dried buds and pre-rolled joints for medical and recreational use.
• Cannabis Extracts: Concentrates, edibles, and oils used for therapy or adult consumption.
• Hemp Wellness: Beauty and wellness items containing ingredients derived from hemp.

Mapping the Expansion

• Obtained majority control of the Cronos GrowCo board of directors in July 2024.
• Entered an agreement in December 2025 to acquire CanAdelaar, a Dutch producer.
• Acquired a junior secured convertible loan and warrant from High Tide Inc.
• Expanded distribution of the PEACE NATURALS brand into the German medical market.

What Makes Cronos Different

Cronos leverages rare cannabinoids and research to create unique products for its brand portfolio. The company manages a global supply chain through its Peace Naturals Campus and its majority interest in Cronos GrowCo.

Performance by the Numbers

• Net revenue reached $53.0 million for the three months ended June 30, 2026, up 58% year over year.
• Gross profit was $28.5 million for the three months ended June 30, 2026, up 96% year over year.
• Net income was $35.7 million for the three months ended June 30, 2026, compared to a net loss of $38.5 million in 2025.
• Total cash, short-term investments, and interest-bearing deposits reached $827.0 million as of June 30, 2026.

Bottom Line

Cronos has evolved from a cultivation-focused startup into a brand-driven global cannabis player. Its strategy emphasizes high-margin international markets and intellectual property to drive long-term value.